Pharma

In the pharmaceutical industry, complete traceability is not a comfort but a duty — and a finding in an audit can get expensive. Every process is subject to good manufacturing and working practices (GxP/GMP), every change has to be checked and released, and data must follow the ALCOA+ principles: clearly attributable, legible, recorded promptly, kept in the original and accurate. Digitalizing without keeping this framework in mind puts the validated state at risk. Keeping it in mind buys you speed at the next release.

Typical challenges

• Strict GxP and GMP requirements on every changed process step
• Data must stay unaltered and traceable under ALCOA+ across its entire life cycle
• New or modified systems require extensive checking and documentation
• Paper and isolated tools often keep running alongside modern systems

How we help

• Introducing AI and cloud in a framework that considers checkability from the start
• Data architectures aligned with ALCOA+ that support complete proof and audit trails
• Accompanying documentation and validation requirements rather than bypassing them
• Gradually replacing paper-based workflows with traceable transitions

In regulated environments we deliberately proceed with care — here, speed comes from diligence, not from shortcuts.